Seeking Your Fortune! Follow Me!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IMO Short Interest will MUCH BIGGER!
DOWNGRADED BY ZACKS! I TOLD YOU!
Strong Buy My ACETONE!
The 10-q serves as ADEQUATE evidence that this company is HIDING SERIOUS problems!
SHORT ANSWER: THEY CAN'T!
BUT, when EXECs at a company are TAKING 1/3 of the GROSS revenues as PAY, I would say there is a MUCH MORE SERIOUS problem. There is a JUDGMENT problem. And, if they can't make GOOD judgments about how MUCH to pay themselves, how can they be TRUSTED to make good operational decisions?
HOW can this be a STRONG BUY when they have to spend 10.6M to make 10.5? That points to a HORRIBLE business plan OR GROSS mis-management!
IMO This is a PRIME example of what NOT to buy! I have lost THOUSANDS on this DOG! This just turned into a WRITE OFF for me!
NO WONDER THEY ARE LOSING MONEY!
1/3 of company's revenue went to PAY EXEC salaries!
WOW! Officers of this company made $800,000 during the 1st Qtr! That is $3.2M a year !!! How can they AFFORD to do this when the company is LOSING MONEY?!
Stock-based compensation was $0.3 million and $0.5 million for the three months ended March 31, 2015
Not much of an improvement in NET cash! Net cash provided by operating activities was $0.7 million for the three months ended March 31, 2015. We received $0.7 million from a state income tax refund, $0.6 million from accounts receivable, and non-cash expenses including stock-based compensation of $0.6 million and depreciation and amortization of $0.5 million. This was partially offset by decreases in deferred revenue of $1.2 million and accounts payable and other accrued liabilities of $0.5 million.
Net cash used by operating activities was $3.6 million for the three months ended March 31, 2014. The primary uses of operating cash were our net loss of $5.2 million and a decrease in our accounts payable and accrued liabilities of $0.7 million. These were partially offset by depreciation and amortization of $0.9 million, non-cash expenses including stock-based compensation of $0.8 million, and other working capital decreases including accounts receivable of $0.6 million.
This doesn't sound good at ALL!
Based on the Company’s current financial revenue and profit projections, our reduced cost structure as a result of our 2014 restructuring, and the proceeds from the sale of our common stock in a private placement in 2014, management believes that the Company’s existing cash, cash equivalents and short-term investments will be sufficient to fund its operations through at least the next twelve months. If market acceptance of our strategy and products is slower than anticipated, then we will need to:
• undertake additional restructuring to lower costs to bring them in line with actual revenues;
• raise additional funds to support the Company’s operations. There is no assurance that the Company will be able to raise such additional funds on acceptable terms, if at all. If the Company raises additional funds by issuing securities, existing stockholders may be diluted; and
• review strategic alternatives for one or more of our product lines.
If adequate funds are not available, we may be required to curtail our operations or other business activities or obtain funds through arrangements with strategic partners or others that may require us to relinquish rights to certain technologies or potential markets.
NO WONDER they have to raise money thru private placements!
This is RIDICULOUS! Real Property Leases
Our corporate headquarters, including our principal administrative, sales and marketing, customer support and research and development facility, is located in Aliso Viejo, California, where we currently lease and occupy approximately 33,600 square feet of space pursuant to lease that expires on May 31, 2016. We lease approximately 55,600 square feet in Pittsburgh, Pennsylvania under a lease that expires December 31, 2021. Internationally, we lease space in Belgrade, Serbia that expires December 30, 2016.
In February 2015, we signed an addendum to sublease approximately 19,965 square feet of our Pittsburgh, Pennsylvania facility for a term that expires on December 31, 2021 which is concurrent with our current lease.
We lease an additional 19,100 square feet in Aliso Viejo, California under a lease that expires January 31, 2022. In August 2014, we signed an addendum to sublease all of the space commencing on September 15, 2014 for a three year period, with two, two-year renewal options. The remaining lease expense, net of sublease income, has been accrued for in our 2013 restructuring liability account.
We lease approximately 15,300 square feet in Watsonville, California under a lease that expires September 30, 2018. In March 2014, we signed an addendum to sublease all of the space commencing on May 1, 2014. We are paying the landlord a minimum amount of rent, with annual escalations, through the end of the lease. This lease expense has been accrued for in our 2013 restructuring liability account. We have moved into a significantly smaller facility in Santa Cruz, California and are paying month-to-month rent.
9.7m cash - 11M in LEASES!
It costed 10.6M to make revenues of 10.5M!
Poetic! I am LOSING money on a company that is LOSING Money!
10-q OUT! Company is reporting a LOSS for the 2nd year in a row! GREAT!
My rating here: BUY and HOLD
We'll see that $100 loss turn into a $600 gain.
You can do it. If you have any positions that aren't outperforming S&P 500, I recommend closing them out to build up a cash reserve. Start buying this at the low point every day. Pretty soon, you will notice that your position has gone green. Keep doing this until you run out of stale cash. Then, HOLD. You will have done your part to keep the shares off of the street. And, you can be certain that the short sellers are going suffer because of it! ; )
The other reason that I am in no rush for this to run back up is because I want the short sellers to continue dumping cheap shares. Since there will be a shortage of shares, the shorts won't be able to cover. They will be forced to pay a lot more than they sold at. In comes the board squeeling, I am looking forward to that. It will let me know that pain is being inflicted. And, it will signal that shorts are going to gap it back up. I will QUADruple my buys when that happens.
All in good time! : )
Make 'em shorts PAY to cover!
The benefit of incremental buying is that it takes shares off of the market. Without open orders, short sellers can't cover. That is part 2 of my plan to make bank here - take all the shares off the market.
To complement this strategy, I enter sale orders on all my shares. That locks them up so the broker can't loan them out.
In fact, that strategy will actually work for any long who wants to use it. If you have stale money, use it to keep you position +. If you run out of stale money, then, just hold here. Good things come to those who wait! ; )
My strategy here has been to buy at the lowest point every day. It is working to keep my position +. My incremental buys get bigger as the price falls.
No way to know for sure that it is the bottom. But, I can tell you where the top will be! : )
I'm sure you are hoping the best for all. LMAO
No need to rush this. Even if this never breaks past the current price, your current shares will bring $4 a piece, post merger. My suggestion is that you quietly load and forget about short sellers and any other item that distrays you from accumulating.
A lot of investors think that way. Although I understand, it can lead to missed oppurtunities. Like, the post merger valuation of a share here. It will be in the neighborhood of $4, and, we will get 1 share for every CLRX share. Even though that only represents 10% of MMMS, it will mean a DOUBLE in our current value. And, a 600% increase in share price from this level.
A rather small victory, to say the least.
I'm not worried about this. All in good time ; ) I am adding and holding.
AMPE - Bull pattern emerging!
HOLY SMOKE! Did someone taint the STRIDE trial? Check this out! http://finance.yahoo.com/mbview/threadview/;_ylt=Ag8Ixlb_bwFRbjXTxPsTcjbeAohG;_ylu=X3oDMTB2Y252cDRkBHBvcwMxOQRzZWMDTWVkaWFNc2dCb2FyZHNYSFJVbHQ-;_ylg=X3oDMTBhYWM1a2sxBGxhbmcDZW4tVVM-;_ylv=3?&bn=17dfabed-4d4e-3bd1-a939-b5b36ec9936f&tid=1430487752073-66bcc833-8f98-4835-8860-0d2110446e03
AMPION FDA APPROVAL POSSIBLE WITHOUT ANOTHER TRIAL!
Ampio determined that the trial failure was due in part because of a huge increase of efficacy in the placebo group (UP TO 60%!) which is typically unheard of. Normally, Placebos fall into the 30% range.
Given it was the crazy variation in the Placebo results, AMPIO may not be required to do another trial. Phase 3 data from the other two trials it is running known as “SPRING” and “STRUT” may be enough to file for a Biologics License Application — BLA.
I can't believe I held this sorry pick!
This stock is HORRIBLE!